At 11pm this evening Britain officially leaves the European Union (EU) and we move into a transitional phase before fully leaving at the end of 2020.\u00a0 This means we will spend much of this year working out how things will look going forwards and in order to do that I think it is worth reflecting from a Centre perspective what we have achieved in the last fifteen years by collaborating with colleagues and institutions in the EU and Europe more broadly. <\/p>\n\n\n\n
We have received European funding\nfrom successive EU funding programmes such as FP6, 7 and now Horizon 2020 as\nwell as Industry\/EU partnership such as the Innovative Medicines Initiative and\nEU Joint Programmes, such as the one for Neurodegenerative Disease. As part of\nthese programmes we have had the opportunity and privilege to visit other\nclinical and academic institutions across the EU and also welcomed them to\nWales.<\/p>\n\n\n\n
We have pushed forward the boundaries of research in the diagnosis and management of acute cough and urinary tract infections in primary care across Europe, provided evidence to improve the use of antibiotics and contributed to the development of exciting new technologies for diagnosing infections. We have also contributed to a better understanding of the patient and public understanding of infections, antibiotics resistance and research into epidemics and pandemics, some of which is now being used to help prepare Europe for the new Coronavirus coming out of China<\/a>.<\/p>\n\n\n\nBRAINTRAIN study<\/h2>\n\n\n\n